Drug Shortage Report for EPIRUBICIN FOR INJECTION
| Report ID | 68608 |
| Drug Identification Number | 02324091 |
| Brand name | EPIRUBICIN FOR INJECTION |
| Common or Proper name | EPIRUBICIN |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | EPIRUBICIN HYDROCHLORIDE |
| Strength(s) | 2MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 5ML |
| ATC code | L01DB |
| ATC description | CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2018-12-01 |
| Estimated end date | 2019-07-30 |
| Actual end date | 2019-07-30 |
| Shortage status | Resolved |
| Updated date | 2019-08-06 |
| Company comments | Will be managing inventory to Market. Demand increase cannot be supported in full but will be working closely to support all demand possible. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v13 | 2019-08-06 | French | Compare |
| v12 | 2019-08-06 | English | Compare |
| v11 | 2019-06-27 | French | Compare |
| v10 | 2019-06-27 | English | Compare |
| v9 | 2019-05-28 | French | Compare |
| v8 | 2019-05-28 | English | Compare |
| v7 | 2019-04-11 | French | Compare |
| v6 | 2019-04-11 | English | Compare |
| v5 | 2018-12-12 | French | Compare |
| v4 | 2018-12-12 | English | Compare |
| v3 | 2018-12-04 | French | Compare |
| v2 | 2018-12-04 | English | Compare |
| v1 | 2018-12-04 | English | Compare |
Showing 1 to 13 of 13